2021 - Managing Domestic and Foreign FDA Inspections and the COVID-19 Impact
Date2021-06-24 - 2021-06-25
Deadline2021-06-14
VenueVirtual Seminar, USA - United States
KeywordsFda inspection seminar; Fda inspection; Fda warning letter
Topics/Call fo Papers
FDA legal authority to inspect
Over products
Over firm’s
Scientific/clinical studies
Premarket requirements
Postmarket requirements
FDA’s annual inspection work plan
Inspection Procedures
FDA inspection Manuals
FDA Training
Documenting violations
Refusals
Human factors
Recall procedures (What FDA expects from you.)
FDA Field Office Management
FDA Center(s) Management
The firm’s job
Inspectional observations (Form FDA-483)
Responding to a 483
Responding to a Warning Letter
FDA enforcement actions
Follow up inspections
Foreign Inspections
Over products
Over firm’s
Scientific/clinical studies
Premarket requirements
Postmarket requirements
FDA’s annual inspection work plan
Inspection Procedures
FDA inspection Manuals
FDA Training
Documenting violations
Refusals
Human factors
Recall procedures (What FDA expects from you.)
FDA Field Office Management
FDA Center(s) Management
The firm’s job
Inspectional observations (Form FDA-483)
Responding to a 483
Responding to a Warning Letter
FDA enforcement actions
Follow up inspections
Foreign Inspections
Other CFPs
- Fundamentals of EU MDR and IVDR – Level 1
- Lifecycle Management of Analytical Methods and Procedures according to new USP and ICH Guidelines
- Designing and Sustaining New and Existing Product Stability Testing Program
- Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)
- Quality and GMP Compliance for Virtual Companies (Pharmaceutical and Biologics Industries)
Last modified: 2021-05-17 04:33:32